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ABSTRACT (250 words) 
Background: Mechanisms underlying immune cells' recruitment and activation into the 
inflammatory lesions of lip salivary glands (LSGs) from primary Sjögren's syndrome 
(pSS) patients are incompletely understood. Chemokines play pivotal roles in these 
processes, so we investigated the clinical significance of chemokine receptor CXCR3 
and its ligands in the autoimmune lesions of pSS. 
Methods: We histologically determined the grade of LSG samples from 22 pSS patients 
and subjected the samples to immunofluorescence analysis to determine the expressions 
of CXCR3 and its ligands: CXCL9, CXCL10, and CXCL11. To identify the immune 
cells expressing CXCR3 in the LSGs, we performed double immunofluorescence 
analysis using antibodies against CD3 (pan-T cells), CD80 (M1 macrophages), CD163 
(M2 macrophage), and CD123 (plasmacytoid dendritic cells: pDCs). The relationship 
between the grade of lymphocytic infiltration and the number of positively stained cells 
was analyzed by Spearman's rank correlation test. 
Results: The expressions of CXCL9 and CXCL10 showed particularly intense staining 
in the LSG samples' ductal cells. The CXCR3 expression was detected mainly in CD80+ 
and CD163+ macrophages. The number of CXCR3+CD163+ macrophages inversely 
correlated with the LSG inflammatory lesions' severity (rs= −0.777, p<0.001). 
 3 
 
Conclusions: Our results suggest that the enhanced production of CXCL9 and CXCL10 
from ductal cells results in the CXCR3+ macrophages' migration. There was an inverse 
correlation between these two parameters: i.e., the number of CXCR3+CD163+ 
macrophages decreased as the lymphocytic infiltration grade increased. Although 
CXCR3 is expressed in all of the innate immune cells, CXCR3+CD163+ M2 
macrophages may contribute to the anti-inflammatory functions in pSS lesions. 
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Introduction 
Primary Sjögren's syndrome (pSS), one of the most common autoimmune diseases, is 
characterized by the eventual total replacement of the acinar structure by marked 
lymphocytic infiltrates in the salivary and lacrimal glands (1). The pathogenesis of this 
selective and progressive destruction of the acinar structure in salivary glands is not yet 
fully understood. However, accumulated evidence indicates a close relationship between 
cytokine expression in salivary gland tissue and the development and progression of this 
disease (2). One of the families of effector molecules under the control of the cytokine 
communication network is the large group of mediators known as chemokines (3). 
CXCR3 is a receptor for CXCL9, CXCL10, and CXCL11, all of which are 
interferon (IFN)-inducible chemokines (4). CXCR3 is well known to contribute to the 
migration, activation and differentiation of a number of immune cells (5-7). In addition, 
CXCR3 plays a major role in a wide range of infections, autoimmune diseases, and 
neoplastic diseases (5-7). CXCR3 is also well known to express on the multiple types of 
cells of the innate immune system, including dendritic cells, natural killer (NK) cells, 
NKT cells, neutrophils, and macrophages (8, 9). 
Over the years, CXCR3 ligands and their functions in autoimmune diseases such as 
rheumatoid arthritis (RA) have been extensively reported and reviewed (10). In RA 
patients, the recruitment of CXCR3-expressing T cells and mast cells to the inflamed 
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synovium was indeed related to a preferential upregulation of CXCL9 and CXCL10 
expression in the synovial fluid and tissue compared to chemokine levels in traumatic 
arthritis or osteoarthritis (11, 12). Regarding CXCR3 in pSS, Ogawa et al. reported that 
CXCR3 ligands (i.e., CXCL9, CXCL10, and CXCL11) were involved in the 
accumulation of CXCR3+ T cell infiltrates in the salivary glands of pSS patients (13, 14). 
Most of the literature on mammalian systems focuses on the role of CXCR3 in the 
maturation, priming, activation and migration of T cells, but a few studies demonstrated 
that CXCR3 also plays an important role in directing macrophages' activities in some 
animal disease models (15-18). 
Although it is evident that CXCR3 and its ligands contribute to the pathogenesis of 
pSS, an immunopathological analysis to identify the clinical potency of CXCR3 and its 
ligands in pSS has not been performed. Here we conducted an immunopathological 
analysis to clarify the clinical significance of CXCR3 and CXCR3 ligands in the 
autoimmune lesions of pSS. 
 
Materials and Methods 
Ethics statement 
This study was approved by the Institutional Review Board (IRB) of Tokushima 
University Hospital (#2802). Written informed consent was obtained from each 
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individual prior to participation in the study. All of the study participants provided 
signed and informed consent, and this process was documented in an IRB-approved 
consent form. The consent procedure was approved by the Ethics Committee of 
Tokushima University Hospital. This study was conducted in accordance with the 
principles expressed in the Declaration of Helsinki. 
 
Patients 
Twenty-two patients with pSS and 3 healthy controls were enrolled in this study, and 
they were treated at Tokushima University Hospital between 2011 and 2016. All 22 
patients satisfied the revised Japanese Ministry of Health criteria for the diagnosis of SS 
(1999) (19). Moreover, all of the pSS patients also satisfied the American College of 
Rheumatology (ACR) classification criteria for SS (20). 
Table 1 provides a summary of the pSS patients' data. Minor salivary gland 
biopsies in the lower lip were performed in all 22 patients. The biopsy specimens were 
formalin-fixed, paraffin-embedded, and stained with hematoxylin and eosin. The 
lymphocytic focus score (LFS) was recorded as the number of lymphocytic foci 
(defined as aggregates of ≥50 mononuclear cells) per 4 mm2 of salivary tissue (21). 
Based on the biopsy scoring system of Tarpley et al. (22), we categorized the 
LSG biopsy samples into four groups according to the grade of infiltration: the Grade 1 
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group (Tarpley score 1: 1–2 lymphocytic aggregates/lobule), the Grade 2 group 
(Tarpley score 2: 2–3 lymphocytic aggregates/lobule), the Grade 3 group (Tarpley score 
3: diffuse infiltration through acini associated with partial destruction of acinar tissue), 
and the Grade 4 group (Tarpley score 4: diffuse infiltration associated with complete 
loss of tissue architecture).  
The healthy controls (all females, mean age 60.3 ± 4.2 years) were subjects who 
had experienced subjective symptoms of oral dryness, but met none of the objective 
criteria for a diagnosis of pSS.  
 
Double immunofluorescence analysis 
To identify the enhanced expression of CXCR3 and its ligands in the LSGs from pSS 
patients and healthy controls, we examined formalin-fixed paraffin-embedded samples 
of those LSGs. Sections were deparaffinized in xylene and rehydrated in graded ethanol 
according to standard procedures. Antigen retrieval was performed by microwave 
treatment in Antigen Unmasking Solution (Vector, Burlingame, CA). Endogenous 
biotin was blocked using Blocking One reagent (Nacalai Tesque, Kyoto). The primary 
antibodies were rabbit polyclonal antibody to human CXCL9, CXCL10, or CXCL11 
(1:100 dilution; abcam, Cambridge, UK) and mouse monoclonal antibody to human 
anti-CXCR3 (1:100 dilution, abcam) at 4°C overnight.  
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    To identify the immune cells expressing CXCR3 and evaluate the number of total 
macrophages, we incubated sections with the primary antibodies: mouse monoclonal 
antibody to human anti-CXCR3 (1:100 dilution, abcam), rabbit monoclonal antibody to 
human anti-CD3 (1:50 dilution, abcam), rabbit polyclonal antibody to human anti-CD80 
(1:100 dilution, abcam), rabbit polyclonal antibody to human anti-CD163 (1:100 
dilution, abcam), rabbit polyclonal antibody to human anti-CD123 (1:100 dilution, 
abcam), or rabbit polyclonal antibody to human anti-CD68 (pan-macrophages) (1:50 
dilution; abcam) at 4°C overnight. After three washes in phosphate-buffered saline 
(PBS), the sections were incubated with Alexa Fluor 568 goat anti-mouse IgG (H+L) 
(1:200 dilution, Invitrogen, Carlsbad, CA) for 30 min. The sections were washed in PBS, 
then incubated with Alexa Fluor 488 goat anti-rabbit IgG (H+L) (1:100 dilution, Cell 
Signaling Technology, Beverly, MA) for 2 hr at room temperature. The nuclei were 
stained with 4',6-diamidino-2-phenylindole (DAPI). 
The sections were visualized with a laser scanning confocal microscope (Nikon 
A1, Tokyo) or a light microscope equipped with a digital camera (BZ-X700; Keyence, 
Tokyo). The number of CXCR3+ cells per 1.5 mm2 (objective magnification: ×10) was 
counted from six different areas. The numbers of CD68+ macrophages and 
CXCR3+CD163+ macrophages per 0.4 mm2 (objective magnification: ×20) were 
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counted from six different areas. The positively stained populations were counted using 
BZ-X Analyzer software (Keyence). 
 
Statistical analysis 
The relationship between the grade of lymphocytic infiltration and the number of 
CXCR3+ cells, or the number of CXCR3+CD163+ macrophages were analyzed by 
Spearman's rank correlation test. SPSS Statistics-15.0 J software was used for the 
analyses. Statistical tests were two-sided, and significance was defined as a p-value 
<0.05. 
 
Results 
Expression of CXCL9, CXCL10, and CXCL11 in the ductal cells of LSGs from pSS 
patients 
We identified the localization of CXCR3 and its ligands in LSGs by 
immunofluorescence staining. Formalin-fixed paraffin-embedded sections of LSGs 
from pSS patients and normal controls were stained with specific antibodies. Figure 1 
displays representative LSGs of pSS patients and healthy controls. As shown in Figure 
1A, extensive periductal inflammation and parenchymal destruction were apparent in 
the LSGs of the pSS patients compared to those of the controls (Fig. 1B). The results of 
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the immunofluorescence study clearly demonstrated the enhancement of CXCL9 (Fig. 
1C), CXCL10 (Fig. 1E), and CXCL11 (Fig. 1G) expression in the pSS ductal cells and, 
to a lesser extent, in the pSS acinar cells. The expressions of CXCL9 and CXCL10 
showed particularly intense staining in the ductal cells of pSS, whereas the expression 
of CXCL9 (Fig. 1D), CXCL10 (Fig. 1F), and CXCL11 (Fig. 1H) was not detected in the 
normal LSGs. In contrast, as shown in red in Figure 1, CXCR3 was expressed on 
infiltrating cells, but not on intrinsic salivary structures of pSS. Although we expected 
that the CXCR3-expressing cells would be lymphocytes infiltrating around the ductal 
epithelium, most of the infiltrating lymphocytes did not show positive staining for 
CXCR3 (Fig. 1). 
 
Double immunofluorescence analysis for CXCR3/CD3, CXCR3/CD80, CXCR3/CD163, 
and CXCR3/CD123 in LSGs from pSS patients 
We next performed an immunofluorescence analysis to identify the immune cells 
expressing CXCR3 in LSGs of the pSS patients. Although it was reported that 
CXCR3-expressing cells were exclusively activated T cells in SS salivary glands (13), 
our immunofluorescence analysis demonstrated that most of the CD3+ cells did not 
show positive staining for CXCR3 (data not shown). To further clarify the CXCR3 
expression in LSGs of the pSS patients, we performed double immunofluorescence 
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staining for CXCR3 and CD80, CD163, or CD123. Interestingly, the expression of 
CXCR3 was detected in the majority of CD80+ macrophages and CD163+ macrophages 
(Fig. 2). In contrast, CD3+ T cells were marginally stained for CXCR3 in LSGs of the 
pSS patients (Fig. 2). The expression of CXCR3+ was also detected in CD123+ 
plasmacytoid dendritic cells (pDCs) (Fig. 2), but there were few CD123+ pDCs in the 
pSS LSGs (data not shown). These results indicated that the majority of CXCR3+ cells 
infiltrating in LSGs from pSS patients are likely to be macrophages. 
 
Association between the number of CXCR3+ cells and the degree of lymphocytic 
infiltration in LSGs from pSS patients 
We then examined the association between the number of CXCR3+ cells and the degree 
of lymphocytic infiltration. As shown in Figure 3A, a large number of CXCR3+ cells 
was clearly observed in the Grade 1 pSS patients, in which slight lymphocytic 
infiltration was detected. However, when we observed the Grade 4 patients, in which 
diffuse lymphocytic infiltration was associated with a complete loss of tissue 
architecture, the number of CXCR3+ cells was greatly reduced, and these cells were 
observed only around salivary glands. The number of CXCR3+ cells was observed to 
decrease in accord with the infiltration grade. Indeed, the Spearman's rank analysis 
revealed a strong and significant negative correlation between the existence of CXCR3+ 
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cells and the grade of lymphocytic infiltration (rs= −0.871; p<0.001) (Fig. 3B). Based 
on this result, we considered that CXCR3+ cells contributed to the anti-inflammatory 
functions in pSS lesions. Because the expression of CXCR3 was detected in the 
majority of macrophages, we hypothesized that CXCR3+ cells might be M2 
macrophages.  
 
Association between the number of CXCR3+CD163+ macrophages and the degree of 
lymphocytic infiltration in LSGs from the pSS patients 
To investigate this hypothesis, we next evaluated the relationship between 
CXCR3+CD163+ macrophages and the severity of inflammatory lesions in LSGs of the 
pSS patients. CD163 is known to be one of the markers of mature macrophages. Figure 
4A is a photograph of the double immunofluorescence staining for both CXCR3 and 
CD163. The number of CD163+ macrophages expressing CXCR3 decreased in accord 
with the grade of lymphocytic infiltration, and it tended to show a reverse distribution. 
In fact, a strong negative correlation between the number of CXCR3+CD163+ 
macrophages and the grade of lymphocytic infiltration was evident (rs= −0.777; 
p<0.001) (Fig. 4B). The ratio of CXCR3+CD163+ macrophages/total infiltrating 
macrophages (CD68+ macrophages) was 90.98% in Grade 1, 84.15% in Grade 2, 
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91.56% in Grade 3 and 82.46% in Grade 4 (Table 2). Thus, most of the macrophages in 
the pSS lesions were CXCR3+CD163+ macrophages. 
 
Discussion 
The chemokine receptor CXCR3 is well known to contribute to the migration, 
activation, and differentiation of a number of immune cells, and CXCR3 and its ligands 
are clearly shown to play important roles in the pathogenesis of infections, autoimmune 
diseases and neoplastic diseases (5-7). CXCR3 ligands (i.e., CXCL9, CXCL10, and 
CXCL11) were expressed in the salivary glands of pSS patients (13, 14), and 
CXCR3-expressing cells were exclusively activated T cells in the salivary glands of pSS 
patients (13). 
It was also reported that the downregulation of CXCL10 reduced the 
mononuclear cell infiltration in MRL/lpr mice (23). Moreover, in a study of pSS 
patients, the mRNA expressions of chemokines and chemokine receptors in peripheral 
blood mononuclear cells (PBMCs) and LSGs from 18 patients with pSS were measured, 
and the results demonstrated that in the LSGs from the pSS patients, interleukin (IL)-2, 
IFN-γ, CXCL10, CXCR3, macrophage inflammatory protein (MIP)-1α, RANTES 
(regulated upon activation normal T cell expressed and secreted), IL-4, IL-10, TARC 
(thymus- and activation-regulated chemokine), MDC (macrophage-derived chemokine), 
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CCR4 and IL-17 were higher than those in the control LSGs. In the PBMCs, only 
CXCL10 and CXCR3 were expressed at higher levels compared to the controls (24). 
These results suggest the involvement of a Th1 immune response (especially CXCL10 
and CXCR3) in the pathogenesis of pSS. However, a comprehensive analysis of 
CXCR3 in pSS had not been performed; in the present study we thus focused on 
CXCR3 in the autoimmune lesions of pSS. 
Our findings demonstrated that the expressions of CXCL9 and CXCL10 were 
intense in the ductal cells from the pSS patients' LSGs compared to the controls. These 
results are consistent with a previous report (13). Another study indicated that minor 
salivary gland ductal epithelial cells express CXCR3 in both SS patients and healthy 
controls (25), and that the scavenging function of CXCR3 was impaired in SS so that 
minor salivary gland epithelial cells were not able to inhibit chemotaxis of CXCR3+ T 
cells (26). Sfriso et al. detected CXCR3 positivity in SS and normal ductal epithelial 
cells by immunohistochemistry. In order to confirm their findings, we measured the 
localization of CXCR3 in LSGs by immunofluorescence staining. The results of this 
immunofluorescence study demonstrated that CXCR3 was exclusively expressed on 
infiltrating cells, whereas salivary structures were slightly stained for CXCR3 in both 
pSS patients and healthy controls. 
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To identify the immune cells expressing CXCR3 in LSGs from pSS patients, we 
performed double immunofluorescence staining for CXCR3 and CD3, CD80, CD163, 
and CD123. Interestingly, CXCR3 was expressed in the majority of CD163+ 
macrophages and CD80+ macrophages, whereas CD3+ T cells were marginally stained 
for CXCR3 in LSGs of the pSS patients. Although CXCR3 was also expressed in 
CD123+ pDC cells, only a few of these cells showed this expression. Our results 
demonstrated that CXCR3 is expressed in all of the innate immune cells, but the 
majority of CXCR3+ cells in the pSS patients' LSGs are macrophages. These results are 
the first finding regarding CXCR3 in LSGs from pSS patients. 
CXCR3 is well known as a canonical marker of Th1 cells. Although we also 
detected a small number of CXCR3+CD3+ T cells in the salivary gland tissue from pSS 
patients in agreement with the previous studies (13, 14), a much greater increase in the 
number of CXCR3+ macrophages was detectable. Several more recent studies have 
raised interest in the expression of CXCR3 by macrophages. These studies have 
revealed the following: the CXCR3+ macrophage-mediated remodeling of blood vessels 
(15), CXCR3 signaling in diverse processes such as the recruitment of macrophages to 
allografts (16), the promotion of tumor progression by the polarization of CXCR3+ 
macrophages toward an M2 phenotype (17), and the involvement of CXCR3+ 
macrophage-associated inflammation in the CXCL10-mediated sterile inflammatory 
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response in murine nonalcoholic steatohepatitis (NASH) (18). Thus, many reports have 
demonstrated that CXCR3-CXCR3 ligands mediate the recruitment of macrophages in 
various inflammatory lesions. Our present analyses revealed a strong negative 
correlation between the number of CXCR3+ macrophages and the grade of lymphocytic 
infiltration in LSGs of pSS patients, and this is also the first finding of an association 
between CXCR3+ cells and the severity of lesions in LSGs of pSS patients. This result 
suggests that CXCR3 ligands would not directly participate in the regulation of T-cell 
responses, and that the CXCR3 ligands predominantly regulate the recruitment of 
CXCR3+ macrophages in LSGs of patients with pSS. 
Based on this inverse correlation between CXCR3+ macrophages and the severity 
of LSG inflammatory lesions, we considered that CXCR3+ macrophages may contribute 
to the anti-inflammatory functions in pSS lesions. Macrophages are classified as M1 
(classically activated) and M2 (alternatively activated) macrophages based on the 
expression of macrophage gene product, including receptors, cytokines, and effector 
molecules (27). Macrophage polarization was induced by classical 
macrophage-activating stimuli such as Th1-derived IFN or the Th2-derived 
anti-inflammatory cytokines IL-4 and IL-13 (27). M1 macrophages produce 
pro-inflammatory cytokines, such as inducible nitric oxide synthase (iNOS) and tumor 
necrosis factor (TNF) (28). In contrast, M2 macrophages have been shown to contribute 
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to angiogenesis, tissue remodeling, and tumor progression by inducing the expression of 
mannose receptors, scavenging receptors, and angiogenic factors such as vascular 
endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-9 (28, 29). 
Here we performed double immunofluorescence staining for a CXCR3 and CD163 M2 
macrophage marker in the LSGs of pSS patients. 
An earlier study showed that the macrophage incidence was positively correlated 
with the infiltration grade and biopsy focus score (30). Although we could not examine 
the number of CXCR3+CD80+ macrophages, it was evident that the existence of 
CXCR3+CD163+ macrophages was significantly decreased in accordance with the grade 
of lymphocytic infiltration in the pSS patients' LSGs. It is thought that CD163+ 
macrophages are associated with M2 macrophage-like function. 
CXCR3+CD163+macrophages might contribute to the anti-inflammatory functions and 
the tissue remodeling functions in pSS lesions. There would thus be an inverse 
correlation between the number of CXCR3+ macrophages and inflammatory grading in 
the lesions. 
Our study had several limitations. First, this was a pilot study with a small 
number of pSS patients. Second, the correlation with clinicopathologic parameters could 
not be determined due to the small sample size. And third, because we could not 
evaluate the number of CD80+CXCR3+ M1 macrophages, the M1/M2 macrophage 
 18 
 
polarization in the LSGs of pSS could not be examined. Nonetheless, our analysis 
contributed the novel finding that the number of CXCR3+CD163+ M2 macrophages 
decreased as the lymphocytic infiltration grade increased.  
In summary, we detected high levels of CXCL9 and CXCL10 expression in the 
ductal cells of LSGs from pSS patients. The majority of CXCR3+ cells in the pSS 
patients' LSGs were macrophages. The level of CXCR3+CD163+ macrophages was 
inversely correlated with the severity of LSG inflammatory lesions in the pSS patients. 
Our results suggest that the enhanced production of CXCL10 from ductal cells results in 
the migration of CXCR3+ macrophages. CXCR3+CD163+ M2 macrophages may 
contribute to the anti-inflammatory functions in pSS lesions. 
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Table Captions and Figure Legends 
Table 1. Profile of the 22 female pSS patients 
Table 1 footnote: ANA: antinuclear antibody, Anti-SSA/SSB: anti-Sjögren's syndrome 
A and/or B antibodies, CNS: central nervous system, CRP: C-reactive protein, ESSDAI: 
EULAR Sjögren's Syndrome Disease Activity Index, LFS: lymphocytic focus score, 
pSS: primary Sjögren's syndrome, RF: rheumatoid factor, WBC: white blood cell. 
 
Table 2. Incidence of CXCR3+CD163+ macrophages in total infiltrating macrophages in 
LSGs from pSS patients with variable grades 
Table 2 footnote: LSG: lip salivary gland, pSS: primary Sjögren’s syndrome, MΦ: 
macrophage. 
 
Fig. 1. Histological analysis in LSGs from pSS patients and healthy controls. A,E: 
Hematoxylin and eosin (H&E) staining at 4 magnification. Formalin-fixed paraffin 
sections of LSGs from pSS patients (B–D) and healthy controls (F–H) were analyzed 
for the protein expression patterns of CXCL9, CXCL10, CXCL11, and CXCR3. 
Immunofluorescence staining performed with CXCL9 (green), CXCL10 (green), 
CXCL11 (green), CXCR3 (red), and DAPI for staining nuclei (blue). The expressions 
of CXCL9 and CXCL10 showed particularly intense staining in the pSS ductal cells. 
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Most of the infiltrating lymphocytes around the pSS ductal epithelium seemed to not 
express CXCR3. Representative photos of 3–5 samples are shown. Scale bar = 100 µm. 
 
Fig. 2. Double immunofluorescence analysis for CXCR3/CD3, CXCR3/CD80, 
CXCR3/CD163, and CXCR3/CD123 in LSGs from pSS patients. Double 
immunofluorescence staining performed with CXCR3 (red), CD3 (green), CD68 
(green), CD163 (green), CD123 (green), and DAPI for staining nuclei (blue). The 
images for CXCR3 and CD3, CD68, CD163, or CD123 were merged (yellow). CXCR3 
was expressed in the majority of CD68+ and CD163+ macrophages. Although CXCR3 
was expressed in all the innate immune cells, CXCR3+CD3+ cells and CXCR3+CD123+ 
cells were few in number. Representative photos of 3–5 samples are shown. Scale bar = 
50 µm. 
 
Fig. 3. Association of CXCR3+ cells with the degree of lymphocytic infiltration in 
LSGs from pSS patients. A: Immunofluorescence staining performed with CXCR3 
(red) and DAPI for staining nuclei (blue). The existence of CXCR3+ cells decreased 
with the infiltration grade. Representative photos of 3–5 samples are shown. Scale bar = 
100 µm. B: Correlation between the number of CXCR3+ cells and the grade of 
infiltration. The number of CXCR3+ cells per 1.5 mm2 (objective magnification: ×10) 
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was counted from six different areas. The plot displaying the significant negative 
correlation (rs = −0.872; p<0.001) was determined by Spearman's rank correlation test. 
 
Fig. 4. CD163+ macrophages expressing CXCR3 in LSGs from pSS patients. A: 
Double immunofluorescence staining performed with CXCR3 (green), CD163 (red), 
and DAPI for staining nuclei (blue) at LSGs from the four pSS subgroups as classified 
by the grade of the inflammatory lesion. The number of CXCR3+CD163+ macrophages 
decreased in accord with the inflammatory grade. Representative photos of 3–5 samples 
are shown. Scale bar = 100 µm. B: Correlation between the number of CXCR3+CD163+ 
macrophages and the grade of infiltration. The number of CXCR3+CD163+ 
macrophages per 0.4 mm2 (objective magnification: ×20) was counted from six 
different areas. The plot displaying the significant negative correlation (rs = −0.777; 
p<0.001) was determined by Spearman's rank correlation test. 
Table 1   Profile of the 22 female pSS patients. 
 
 
 pSS patients     
 Total (n=22) Grade1 (n=5) Grade 2 (n=5) Grade 3 (n=6) Grade 4 (n=6) 
Mean age (years) 61.3 ± 13.7 65.0 ± 9.9 56.2 ± 20.7 61.5 ± 12.7 62.2 ± 12.9 
Stimulated whole saliva (ml/10 min) 4.50 ± 3.78 7.40 ± 2.95 6.56 ± 3.91 3.80 ± 3.57 1.07 ± 0.78 
Laboratory tests      
WBC (×103/µl) 5.18 ± 1.62 4.98 ± 0.91 5.02 ± 2.38 5.35 ± 1.45 5.30 ± 1.91 
CRP (mg/dl) 0.21 ± 0.63 0.10 ± 0.11 0.08 ± 0.18 0.09 ± 0.10 0.51 ± 1.21 
Autoimmune tests      
ANA positive, n (%) 20 (90.9) 3 (60.0) 5 (100) 6 (100) 6 (100) 
Anti-SSA positive, n (%) 17 (77.3) 3 (60.0) 3 (60.0) 5 (83.3) 6 (100) 
Anti-SSB positive, n (%) 4 (18.2) 0 (0) 1 (20.0) 1 (16.7) 2 (33.3) 
RF positive, n (%) 8 (22.7) 1 (20.0) 1 (20.0) 2 (33.3) 4 (66.7) 
LFS, n (%)      
Score <1 4 (18.2) 2 (40.0) 2 (40.0) 0 (0) 0 (0) 
Score ≥1 18 (81.8) 3 (60.0) 3 (60.0) 6 (100) 6 (100) 
ESSDAI domains      
Constitutional, n (%) 1 (4.5) 0  (0) 0 (0) 1 (16.7) 0 (0) 
Lymphadenopathy, n (%) 0 (0) 0  (0) 0 (0) 0 (0) 0 (0) 
Salivary/parotid 
enlargement, n (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Articular, n (%) 10 (45.5) 1 (20.0) 2 (40.0) 3 (50.0) 4 (66.7) 
Skin, n (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Pulmonary, n (%) 2 (9.1) 1 (20.0) 0 (0) 0 (0) 1 (16.7) 
Renal, n (%) 2 (9.1) 0 (0) 0 (0) 0 (0) 2 (33.3) 
Muscular, n (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Peripheral neuropathy, n (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
CNS involvement, n (%) 1 (4.5) 0 (0) 0 (0) 0 (0) 1 (16.7) 
Hematological, (%) 1 (4.5) 0 (0) 0 (0) 1 (16.7) 0 (0) 
Biological, n (%) 8 (36.4) 0 (0) 2 (40.0) 3 (50.0) 3 (50.0) 
Total ESSDAI score 3.14 ± 3.58 1.80 ± 2.49 1.40 ± 0.89 3.17 ± 3.37 5.67 ± 4.93 
Other autoimmune disorders, n (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
 
pSS: primary Sjögren’s syndrome, WBC: white blood cell, CRP: C-reactive protein, ANA: antinuclear 
antibody, Anti-SSA/SSB: Anti-Sjögren’s syndrome A and/or B antibodies, RF: rheumatoid factor, LFS: 
lymphocytic focus score, ESSDAI: EULAR Sjögren’s syndrome disease activity index, CNS: central 
nervous system. 
 
 
Table 2   Incidence of CXCR3+CD163+ macrophages in total infiltrating macrophages in LSGs from 
pSS patients with variable grade. 
 
 
 Grade 1 
(n=5) 
Grade 2 
(n=5) 
Grade 3 
(n=6) 
Grade 4 
(n=6) 
CXCR3+CD163+-MΦ 
(cells/ 0.4 mm2) 
31.37 ± 10.67 27.03 ± 13.72 15.08 ± 6.93 13.03 ± 7.52 
CXCR3+CD163+-MΦ 
/total MΦ (%) 
90.98 ± 11.50 84.15 ± 14.57 91.56 ± 20.12 82.46 ± 10.48 
 
 
LSG: lip salivary gland, pSS: primary Sjögren’s syndrome, MΦ: macrophage. 
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